COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors
Catheter Precision, a US-based medical device company, has announced changes to its executive management and board of directors, including the appointment of Margrit Thomassen as the interim Chief Financial Officer and the naming of David Jenkins as the Chief Executive Officer. The company, focused on electrophysiology products, aims to continue its growth and meet the needs of patients, hospitals, and physicians. The announcement also includes the resignation of Susanne Meline from the Board of Directors and the appointment of John Francis as her replacement. These changes are part of the company's strategic plan for the upcoming year. -
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market
Catheter Precision, Inc. announced the allowance of two new patents (No. 6288592 and No. 015023977-0001) in Great Britain and the European Market for its LockeT product line, further solidifying the company's IP position. These patents demonstrate the company's commitment to the uniqueness of the closure product design, strengthening its global presence in the electrophysiology products market. -
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023
Catheter Precision, Inc. (NYSE American:VTAK) to present its innovative non-invasive 3D mapping system, VIVO, at the Emerging Growth Conference on December 6, 2023. The event offers an opportunity for real-time interaction with the CEO -
-
COMMUNIQUÉ DE PRESSE
Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
-
COMMUNIQUÉ DE PRESSE
Catheter Precision Showcasing its Innovative 3D Mapping System
-
